Cargando…

Prevalence and Subtypes of Mild Cognitive Impairment in Parkinson’s Disease

The current study examined the prevalence and subtypes of Mild Cognitive Impairment (MCI) in an Australian sample of people with Parkinson’s Disease (PD). Seventy participants with PD completed neuropsychological assessments of their cognitive performance, using MDS Task Force Level II diagnostic cr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lawrence, Blake J., Gasson, Natalie, Loftus, Andrea M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030649/
https://www.ncbi.nlm.nih.gov/pubmed/27650569
http://dx.doi.org/10.1038/srep33929
_version_ 1782454716101296128
author Lawrence, Blake J.
Gasson, Natalie
Loftus, Andrea M.
author_facet Lawrence, Blake J.
Gasson, Natalie
Loftus, Andrea M.
author_sort Lawrence, Blake J.
collection PubMed
description The current study examined the prevalence and subtypes of Mild Cognitive Impairment (MCI) in an Australian sample of people with Parkinson’s Disease (PD). Seventy participants with PD completed neuropsychological assessments of their cognitive performance, using MDS Task Force Level II diagnostic criteria for PD-MCI. A cut-off score of less than one standard deviation (SD) below normative data determined impaired performance on a neuropsychological test. Of 70 participants, 45 (64%) met Level II diagnostic criteria for PD-MCI. Among those with PD-MCI, 42 (93%) were identified as having multiple domain impairment (28 as amnestic multiple domain and 14 as nonamnestic multiple domain). Single domain impairment was less frequent (2 amnestic/1 nonamnestic). Significant differences were found between the PD-MCI and Normal Cognition groups, across all cognitive domains. Multiple domain cognitive impairment was more frequent than single domain impairment in an Australian sample of people with PD. However, PD-MCI is heterogeneous and current prevalence and subtyping statistics may be an artifact of variable application methods of the criteria (e.g., cut off scores and number of tests). Future longitudinal studies refining the criteria will assist with subtyping the progression of PD-MCI, while identifying individuals who may benefit from pharmacological and nonpharmacological interventions.
format Online
Article
Text
id pubmed-5030649
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-50306492016-09-26 Prevalence and Subtypes of Mild Cognitive Impairment in Parkinson’s Disease Lawrence, Blake J. Gasson, Natalie Loftus, Andrea M. Sci Rep Article The current study examined the prevalence and subtypes of Mild Cognitive Impairment (MCI) in an Australian sample of people with Parkinson’s Disease (PD). Seventy participants with PD completed neuropsychological assessments of their cognitive performance, using MDS Task Force Level II diagnostic criteria for PD-MCI. A cut-off score of less than one standard deviation (SD) below normative data determined impaired performance on a neuropsychological test. Of 70 participants, 45 (64%) met Level II diagnostic criteria for PD-MCI. Among those with PD-MCI, 42 (93%) were identified as having multiple domain impairment (28 as amnestic multiple domain and 14 as nonamnestic multiple domain). Single domain impairment was less frequent (2 amnestic/1 nonamnestic). Significant differences were found between the PD-MCI and Normal Cognition groups, across all cognitive domains. Multiple domain cognitive impairment was more frequent than single domain impairment in an Australian sample of people with PD. However, PD-MCI is heterogeneous and current prevalence and subtyping statistics may be an artifact of variable application methods of the criteria (e.g., cut off scores and number of tests). Future longitudinal studies refining the criteria will assist with subtyping the progression of PD-MCI, while identifying individuals who may benefit from pharmacological and nonpharmacological interventions. Nature Publishing Group 2016-09-21 /pmc/articles/PMC5030649/ /pubmed/27650569 http://dx.doi.org/10.1038/srep33929 Text en Copyright © 2016, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Lawrence, Blake J.
Gasson, Natalie
Loftus, Andrea M.
Prevalence and Subtypes of Mild Cognitive Impairment in Parkinson’s Disease
title Prevalence and Subtypes of Mild Cognitive Impairment in Parkinson’s Disease
title_full Prevalence and Subtypes of Mild Cognitive Impairment in Parkinson’s Disease
title_fullStr Prevalence and Subtypes of Mild Cognitive Impairment in Parkinson’s Disease
title_full_unstemmed Prevalence and Subtypes of Mild Cognitive Impairment in Parkinson’s Disease
title_short Prevalence and Subtypes of Mild Cognitive Impairment in Parkinson’s Disease
title_sort prevalence and subtypes of mild cognitive impairment in parkinson’s disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030649/
https://www.ncbi.nlm.nih.gov/pubmed/27650569
http://dx.doi.org/10.1038/srep33929
work_keys_str_mv AT lawrenceblakej prevalenceandsubtypesofmildcognitiveimpairmentinparkinsonsdisease
AT gassonnatalie prevalenceandsubtypesofmildcognitiveimpairmentinparkinsonsdisease
AT loftusandream prevalenceandsubtypesofmildcognitiveimpairmentinparkinsonsdisease